Social Media Ideas for Amyloid-Beta

Latest updates for Amyloid-Beta

Fresh curated links around amyloid-beta are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fightaging.org /1 month ago

PM20D1 Creates N-oleoyl-Leucine to Improve Clearance of Amyloid-β Aggregates by Microglia

Researchers here note a mechanism that encourages the innate immune cells known as microglia to better clear amyloid-β in the aging brain. The protein PM20D1 acts in the formation...

Read source

neurosciencenews.com /4 weeks ago

Alzheimer’s Protein APP Acts as Vital Shield for Neurons

A new study reveals that amyloid precursor protein (APP), long studied merely as the source of toxic plaques in Alzheimer's disease, serves a vital protective role as a cellular gu...

Read source

bioengineer.org /3 days ago

Clinicopathologic Study Reveals Amyloid Clearance in Alzheimer’s Disease

A recent case report published in JAMA has shed new light on the mechanisms involved in amyloid clearance following amyloid-targeting therapies for Alzheimer’s disease. This ground...

Read source

sciencedaily.com /1 month ago

Scientists found a hidden Alzheimer’s trigger and shut it down

A newly identified enzyme called IDOL could become a major new target in the fight against Alzheimer’s disease. Researchers found that removing it from neurons sharply reduced amyl...

Read source

bioengineer.org /1 month ago

Microglial CD31 Hinders Aβ Clearance, Worsens Alzheimer’s

In a groundbreaking study that promises to reshape our understanding of Alzheimer’s disease, researchers have unveiled a novel mechanism by which microglial cells may exacerbate di...

Read source

sciencedaily.com /3 weeks ago

Scientists May Have Found What Really Triggers Alzheimer’s Disease

Scientists may have uncovered a hidden trigger behind Alzheimer’s disease. Instead of plaques being the root cause, amyloid beta appears to interfere with tau, a protein that helps...

Read source

fightaging.org /1 week ago

Arc is Involved in Transmission of Tau Between Neurons in Alzheimer's Disease

The more severe later stages of Alzheimer's disease are characterized by altered forms of tau protein aggregating inside neurons to cause dysfunction, inflammation, and cell death....

Read source

sciencedaily.com /3 weeks ago

Scientists reprogram brain immune cells to fight Alzheimer’s

A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s models. The treatment reduced toxic plaque buildup and impr...

Read source

fightaging.org /1 month ago

APOE2 Allele of APOE Makes Neurons More Resilient in Cell Cultures

The Apolipoprotein E (APOE) gene exhibits a small number of common sequence variants across the human population, of which the desirable APOE2 variant is associated with modestly g...

Read source

lifespan.io /1 month ago

Neurons’ Protein Disposal Trick Offers Alzheimer’s Insights

According to a new study, a special protein disposal system, currently found only in neurons, is linked to central hallmarks of Alzheimer’s disease [1]. The membranal proteasome Al...

Read source

fiercebiotech.com /2 days ago

AAIC: Biogen bolsters hopes for Alzheimer's pivotal push as anti-tau oligo slows cognitive decline

Biogen's leading tau-targeting candidate has slowed cognitive decline across a suite of different clinical assessments, backing up the pharma’s decision to race the molecule into p...

Read source

neurosciencenews.com /1 week ago

Study Aims to Stop Alzheimer’s Inflammation in APOE4 Carriers

The project uses artificial intelligence and small-molecule targeting to inhibit the cPLA2 enzyme, providing a novel pathway to shut down brain inflammation in high-risk APOE4 gene...

Read source

bioengineer.org /2 weeks ago

Unlocking the Mysteries of Alzheimer’s Disease

An interdisciplinary team of researchers at the University of Southern California’s Center for Personalized Brain Health (CPBH) has embarked on a groundbreaking investigation targe...

Read source

drsvenkatesan.com /5 days ago

The tough task of reversing cardiac Amyloidosis : Classification of “Anti-Amyloid”drugs

Amyloidosis is a proteostatic disease , meaning a progressive disorder of extracellular deposition of insoluble protein fibrils in tissues.It affects , brain, kidney, nerves and al...

Read source

neurosciencenews.com /2 weeks ago

Arc Protein Found to Spread Toxic Tau in Alzheimer’s

The native brain protein Arc mediates the intercellular transmission of toxic Tau via extracellular vesicles in Alzheimer's disease. While Arc helps sick neurons survive longer by...

Read source

scitechdaily.com /1 week ago

New Molecule Restores the Brain’s Natural Defenses Against Alzheimer’s

Scientists have developed an experimental molecule that helps the brain’s immune cells fight Alzheimer’s again, reducing toxic plaques and improving memory in animal studies. Scien...

Read source

sciencedaily.com /1 month ago

USC scientists discover a hidden Alzheimer’s trigger and a possible way to shut it down

USC researchers have identified potential new drug compounds that may reduce the brain inflammation linked to Alzheimer’s disease, especially in people with the high-risk APOE4 gen...

Read source

nbcdfw.com /2 days ago

Experimental Alzheimer's drug shows promise targeting brain protein tau in study

An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers r...

Read source

biopharmadive.com /1 month ago

In Alzheimer’s, Bristol Myers sees big promise beyond amyloid

Bristol Myers' neuroscience heads are trying to make a name in brain drugs for a company best known for its cancer and cell therapy work.

Read source

fightaging.org /1 month ago

GRK2 Aggregation as a Cause of Mitochondrial Dysfunction in Alzheimer's Disease

Here researchers report on a novel form of pathological protein aggregation in the aging brain and evidence for it to contribute to mitochondrial dysfunction in Alzheimer's disease...

Read source

fiercebiotech.com /1 day ago

AAIC: Roche ‘very interested’ in testing tau for Alzheimer’s despite focus on phase 3-stage amyloid drug

Roche’s biggest bet in the Alzheimer’s disease space may be its phase 3-stage amyloid asset, but the Swiss pharma is keeping its options open when it comes to targeting tau.

Read source

sciencedaily.com /1 month ago

Copper drug clears toxic Alzheimer’s proteins and restores memory

A copper-based compound restored the brain’s ability to clear toxic Alzheimer’s proteins, dramatically reducing amyloid buildup and improving memory in laboratory experiments. The...

Read source

lifespan.io /3 weeks ago

Glycosylation’s Role in Alzheimer’s Disease

A recent study suggests that hyperglycosylation in brain tissue can be a hallmark of Alzheimer’s disease [1]. Lesser-known Alzheimer’s molecular […]

Read source

sciencealert.com /3 weeks ago

A Copper-Based Drug Clears Buildup of Alzheimer's Proteins in Mice

A promising start.ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.